1-(3,4-Dimethoxyphenethylamino)-3-(3,4-dihydroxyphenoxy)-2-propanol
CAS: 74513-77-2
Ref. 3D-ZCA51377
| 1g | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar | |
| 250mg | A consultar | |
| 500mg | A consultar |
Informação sobre produto
1-(3,4-Dimethoxyphenethylamino)-3-(3,4-dihydroxyphenoxy)-2-propanol (CGP3466B) is a cardiotonic agent that has been shown to increase the contractility of cardiac muscle. It also has a positive inotropic effect on cardiac tissue, thereby increasing the strength of contraction and pumping capacity. CGP3466B is used for the treatment of cachexia in animals. Cachexia is a condition characterized by weight loss and muscle atrophy. This drug modulates acetylcholine levels in the brain and has been shown to have a beneficial effect on metabolic disorders such as diabetes mellitus. CGP3466B can be administered orally or intravenously. The plasma concentrations peak at approximately 4 hours after administration and then decline exponentially with a half-life of 18 hours. When given orally, this drug reaches maximal concentrations in the blood within 3 hours and remains there up to 12 hours
Propriedades químicas
Consulta técnica sobre: 3D-ZCA51377 1-(3,4-Dimethoxyphenethylamino)-3-(3,4-dihydroxyphenoxy)-2-propanol
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
